Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07311668
Eligibility Criteria:
1. Subjects with anxiety disorders （1）Inclusion Criteria:
* In accordance with ICD-11 for Depressive Disorders;
* Between the ages of 18-60;
* Ability to use computers or smartphone;
* Native Chinese speaker;
* Signing informed consent. （2）Exclusion Criteria:
* With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
* With a high risk of suicide or self-injury;
* With severe physical diseases, central nervous system diseases, or substance abuse;
* With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
2. Health Control （1）Inclusion Criteria:
* Not meet ICD-11 criteria for Mental Disorders;
* Between the ages of 18-60;
* Ability to use computers or smartphone;
* Native Chinese speaker;
* Signing informed consent. （2）Exclusion Criteria:
* With mental illness, or unable to complete the required assessment and treatment;
* With severe physical diseases, central nervous system diseases, or substance abuse;
* With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
3. Psychiatrist （1）Inclusion Criteria:
* Over 18 years old;
* A minimum of three years' experience in anxiety and other mental health fields;
* Intermediate or higher professional title;
* Currently employed in the selected test region;
* Signing informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT07311668
Study Brief:
Protocol Section:
NCT07311668